High throughput sequencing technologies have proven to be critical tools in understanding the molecular basis of disease, particularly in oncology. Recent advances have enabled characterization of the genetic mechanisms of cancer, revealing variants associated with novel pathways that determine tumor formation and response to treatment. The clinical potential of sequencing technologies in the diagnosis and treatment of diseases has now been demonstrated, but challenges remain, particularly in sample preparation and data interpretation. In this webinar our expert panel will describe recent discoveries in cancer genomics and inherited diseases, and how these advances are enabling personalized medicine and the individualization of treatment.
During this webinar, viewers will:
- Gain insight into how mining tumor genomes can lead to better understanding of cancer
- Learn how technologies are being applied to tumor genome analysis
- Improve their understanding of the pain points in genome analysis and how they can be overcome
- Have the opportunity to ask questions of the expert panel, live!
For more information on products/technologies related to this webinar, go to: www.perkinelmer.com/ngs